News

The latest bout of meme stock mania, in which retail investors are pocketing quick fortunes by piling into heavily-shorted stocks like Kohl’s Corp. and Opendoor Technologies Inc., is likely getting ...
Delhi Chief Minister Rekha Gupta on Thursday rolled out the expanded Health Information Management System (HIMS) and said that people will no longer need to queue up to take appointments as it will be ...
Delhi Chief Minister Rekha Gupta launched the expanded Health Information Management System (HIMS) to simplify appointment bookings and digitize patient records. With over 93 lakh ABHA IDs generated, ...
Delhi Chief Minister Rekha Gupta on Thursday rolled out the expanded Health Information Management System (HIMS) and said that people will no longer need to queue up to take appointments as it will be ...
More importantly, Hims & Hers expanded its subscriber base to 2.4 million customers -- a 38% increase -- with nearly 60% now using personalized treatment solutions that command premium pricing.
Delhi Chief Minister Rekha Gupta on Thursday dedicated the state-of-the-art Hospital Information Management System (HIMS), along with 34 Ayushman Arogya Mandirs and eight Jan Aushadhi Kendras to the ...
Explore more
On today's episode of The Roommates Show the guys hand out their NBA Awards! They relive their most controversial moments, ...
Stock indexes in the U.S. moved upward Wednesday as the gained 1.14%. Meanwhile, the increased 0.78%, and the rose 0.61%.
Justin Penik invites the Giants RB1 Tyrone Tracy Jr. to the Jomboy Media Office to talk about his rookie season, goals going ...
HIMS stock up 16% on Wednesday, continuing month-long gains. Novo Nordisk ends partnership, cites misleading marketing and ...
The more cautious voices point to Hims’s high P/E ratio and recent volatility, warning that the stock could cool off after its sharp run-up. That said, a few analysts are still pretty optimistic. They ...
Analysts have provided Laboratory Corp with 8 ratings, resulting in a consensus rating of Neutral. The average one-year price target stands at $276.5, suggesting a potential 9.69% upside.